Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Boule Diagnostics Major Shareholding Notification 2019

Aug 13, 2019

3143_iss_2019-08-13_7e4ae0fe-31fc-4e7a-b790-3dc2a0634b19.pdf

Major Shareholding Notification

Open in viewer

Opens in your device viewer

Issuer Boule Diagnostic AB

Holder

Nordea Funds Ltd

Instrument

Instrument Equity SE0011231158
Before the transaction
Shares Data not given*
Voting rights Data not given*
Transaction
Reason for major shareholding notification Buy
Date 12/08/2019
Limit for number of shares 5 %
Limit for number of votes 5 %
After the transaction
Quantity
Shares 1,121,976
Directly held voting rights 1,121,976
Indirectly held voting rights 0
Percentage
Directly held shares 5.77845 %
Directly held voting rights 5.77845 %
Indirectly held voting rights 0 %

Resulting distribution of total holdings

Percentage of voting
rights:
Number of underlying
shares:
Shares 5.77845 % 1,121,976
Instruments - FITA Ch. 4, section 2, first
paragraph, line 2
Instruments - FITA Ch. 4, section 2,
first paragraph, line 3
- Physically settled
- Cash settled
Total 5.77845 % 1,121,976
Group total holdings
Voting rights
1,121,976
Percentage of voting rights 5.77845
Published
13/08/2019 10:32
Contact
Name
Rasmus Kroner
Phone
+45 55 472 411 Email [email protected]
*Source of information has chosen not to submit the data
CLOSE
PRINT

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25